C I U TRUST
The CIU Trust receives funds from the licensing of sales of reagents for medical research. It aims to promote and support investigation into and study of the sciences of immunology, pathology and allied subjects and to disseminate the useful results of such research.
Objects
THE OBJECTS ARE TO PROMOTE AND SUPPORT BY ALL AVAILABLE MEANS FOR THE PUBLIC BENEFIT RESEARCH AND INVESTIGATION INTO AND STUDY OF THE SCIENCES OF IMMUNOLOGY, PATHOLOGY AND ALLIED SUBJECTS AND TO DISSEMINATE THE USEFUL RESULTS OF SUCH RESEARCH BY ANY MEANS.THE TRUSTEES MUST USE THE INCOME AND MAY USE THE CAPITAL OF THE TRUST IN PROMOTING THE OBJECTS.
Financial health, per its FY2025 accounts
The accounts state that total unrestricted funds increased to £4,819,061, supported by investment income and royalties. The trustees report that the charity has adequate resources to continue in operational existence for the foreseeable future, with no material uncertainties identified regarding its ability to continue as a going concern.
What the accounts disclose
“The Trustees aim to retain sufficient unrestricted reserves to ensure the long term sustainability of the Charity and to allow it the flexibility to practically consider all grant applications of any reasonable value.” — page 4
Policies the charity declares
- Bullying and harassment policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Risk management
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2024
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2023
- Grant-making is its main activity
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Professor Neil Barclaychair
- Dr Eva Gluenz
- Dr Marion Hanbury Brown
- Professor Anton van der Merwe
- Professor Omer Dushek
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £818k | £96k |
| 31/03/2024 | £673k | £541k |
| 31/03/2023 | £657k | £397k |
| 31/03/2022 | £605k | £-2k |
| 31/03/2021 | £527k | £131k |
Common questions
Is C I U TRUST financially healthy?
Per its FY2025 accounts: The accounts state that total unrestricted funds increased to £4,819,061, supported by investment income and royalties. The trustees report that the charity has adequate resources to continue in operational existence for the foreseeable future, with no material uncertainties identified regarding its ability to continue as a going concern. Its FY2025 accounts were audited by Gravita Audit Oxford LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE ROSE ANIMAL WELFARE TRUST CIO | 1 | £12k |
| THE KNOLL CHARITABLE TRUST | 1 | £250 |
Charities like this
- THE C P CHARITABLE TRUST
- THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND
- THE ROMAN RESEARCH TRUST
- SOCIETY FOR MEDICINES RESEARCH
- MEDICAL AND LIFE SCIENCES RESEARCH FUND
- DARTMOUTH STREET TRUST
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| C I U TRUST | £818k | — | 0 | unclear | — | no doubt |
| THE C P CHARITABLE TRUST | £330k | — | 0 | unclear | — | no doubt |
| THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND | £104k | — | 0 | unclear | — | no doubt |
| THE ROMAN RESEARCH TRUST | £33k | — | 0 | above | — | no doubt |
| SOCIETY FOR MEDICINES RESEARCH | £79k | — | — | unclear | — | no doubt |
| MEDICAL AND LIFE SCIENCES RESEARCH FUND | £65k | — | 0 | unclear | — | no doubt |